# Dopamine Hydrochloride Injection: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current, To Be Discontinued
- FDA package records: 12
- Latest FDA row update: 08/27/2025
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Baxter Healthcare — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02) — FDA availability: Available — updated: 08/17/2026
- Baxter Healthcare — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03) — FDA availability: Available — updated: 08/17/2026
- Hikma Pharmaceuticals USA, Inc. — Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25) — FDA availability: Unavailable — updated: 08/13/2026
- Hikma Pharmaceuticals USA, Inc. — Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25) — FDA availability: Unavailable — updated: 08/13/2026
- Hospira, Inc., a Pfizer Company — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-7809-22) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-7810-22) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24) — FDA availability: Unavailable — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dopamine Hydrochloride in Dextrose 5% in plastic container, Injection, 800 mg/500 mL (1,600 mcg/mL) (NDC 0409-7809-24) — FDA availability: Not stated — updated: 08/27/2025
- Hospira, Inc., a Pfizer Company — Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01) — FDA availability: Available — updated: 08/07/2026
- Hospira, Inc., a Pfizer Company — Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20) — FDA availability: Available — updated: 08/07/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/dopamine-hydrochloride-injection)
- [JSON record](https://citefacts.com/shortages/dopamine-hydrochloride-injection.json)